Deltex is a company that specializes in advanced hemodynamic monitoring solutions for improving patient outcomes. They provide monitoring systems and probes that measure blood flow and fluid responsiveness in real-time.
Deltex Medical Group was established in 1993.
The company was founded in Chichester, United Kingdom.
The initial focus of Deltex was on the development and commercialization of its proprietary CardioQ-ODM technology.
Deltex became a public company in 2000 and was listed on the AIM market of the London Stock Exchange.
Over the years, Deltex has expanded its product portfolio and gained recognition in the medical community for its innovative monitoring solutions.
They have received multiple awards and certifications for their products, including FDA clearance and CE marking.
Deltex has continued to evolve and improve its technology, contributing to advancements in hemodynamic monitoring.
As of now, Deltex operates globally, serving healthcare professionals and institutions worldwide.
Edwards Lifesciences is a global medical technology company that offers a range of products for heart disease treatment and critical care monitoring. They provide monitoring systems similar to Deltex's solutions.
LiDCO Group specializes in hemodynamic monitoring technologies and offers a range of monitors and disposable sensors. Their products are designed to optimize fluid management and patient outcomes.
Cheetah Medical is a company that focuses on non-invasive fluid management technologies. They offer hemodynamic monitoring systems and tools for critical care settings.
The CardioQ-ODM is Deltex's flagship product, providing real-time monitoring of patient's hemodynamic parameters. It helps optimize fluid management and enables early detection of complications.
Deltex offers a range of probes designed for oesophageal doppler monitoring. These probes provide accurate blood flow measurements to guide patient management in various clinical settings.
Deltex's monitoring system utilizes Doppler ultrasound technology to measure blood flow and other hemodynamic parameters. This information is then displayed in real-time, allowing clinicians to make informed decisions for patient care.
Deltex's hemodynamic monitoring solution aids in optimizing fluid management, reducing complications, and improving patient outcomes. It provides timely and accurate information for guiding clinical interventions.
No, Deltex's oesophageal Doppler monitoring probes are single-use disposable items. This helps ensure patient safety and avoids the risk of cross-contamination between patients.
Yes, Deltex's monitoring systems and probes have received FDA clearance, attesting to their safety and efficacy. They have also acquired CE marking, meeting the European standards for medical devices.
Deltex's products are available through authorized distributors and directly from the company's website. For specific purchasing information, it is recommended to contact Deltex or their authorized partners.